Bard Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$13M Buy
510,321
+5,716
+1% +$141K 1.43% 13
2025
Q2
$12.2M Sell
504,605
-3,906
-0.8% -$91.1K 1.46% 14
2025
Q1
$12.9M Sell
508,511
-9,836
-2% -$257K 1.58% 10
2024
Q4
$13.8M Buy
518,347
+838
+0.2% +$22.7K 1.65% 9
2024
Q3
$15M Buy
517,509
+1,146
+0.2% +$33.4K 1.77% 10
2024
Q2
$14.4M Buy
516,363
+38,502
+8% +$1.06M 1.49% 12
2024
Q1
$13.3M Buy
477,861
+53,937
+13% +$1.5M 1.41% 14
2023
Q4
$12.2M Buy
423,924
+81,245
+24% +$2.46M 1.37% 12
2023
Q3
$11.4M Buy
342,679
+30,235
+10% +$1.07M 1.4% 13
2023
Q2
$11.5M Buy
312,444
+1,425
+0.5% +$55.5K 0.87% 23
2023
Q1
$12.7M Buy
311,019
+3,025
+1% +$131K 1.02% 21
2022
Q4
$15.8M Buy
307,994
+4,725
+2% +$227K 1.34% 16
2022
Q3
$13.3M Buy
303,269
+10,325
+4% +$502K 1.24% 18
2022
Q2
$15.4M Sell
292,944
-200
-0.1% -$10.2K 1.4% 16
2022
Q1
$15.2M Buy
293,144
+9,825
+3% +$510K 1.24% 16
2021
Q4
$16.7M Sell
283,319
-9,800
-3% -$486K 1.35% 17
2021
Q3
$12.6M Sell
293,119
-275
-0.1% -$12.2K 1.12% 18
2021
Q2
$11.5M Buy
293,394
+3,950
+1% +$154K 1.02% 21
2021
Q1
$10.5M Sell
289,444
-11,590
-4% -$412K 1.02% 21
2020
Q4
$11.1M Buy
+301,034
New +$11M 1.11% 22

Other funds holding PFE

Bard Financial Services's PFE Position: Q3 2025 in Review

Bard Financial Services increased its Pfizer (PFE) stake by 1.1% in Q3 2025, buying an estimated $141K and bringing the position to 510,321 shares worth $13M. The position accounts for 1.43% of the portfolio, ranked #13.

Bard Financial Services first reported a position in PFE in Q4 2020 and has held it in 20 quarters since. The position peaked at $16.7M in Q4 2021. 2,817 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Bard Financial Services held 510,321 shares of Pfizer worth $13M as of Q3 2025.
  • Bard Financial Services bought 5,716 Pfizer shares in Q3 2025, an estimated $141K.
  • Pfizer made up 1.43% of Bard Financial Services's portfolio in Q3 2025, its #13 holding.
  • Bard Financial Services first reported a position in Pfizer in Q4 2020 and has held it in 20 quarters since.
  • Bard Financial Services's Pfizer position peaked at $16.7M in Q4 2021.
  • 2,817 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Bard Financial Services's 13F filing for Q3 2025, filed 17 Oct 2025.